Drug Profile
Perflubron - Oxygent
Alternative Names: AF 0144; OxygentLatest Information Update: 07 Dec 2015
Price :
$50
*
At a glance
- Originator Alliance Pharmaceutical Corporation
- Class Fluorocarbons; Small molecules
- Mechanism of Action Oxygen carriers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypoxia
Most Recent Events
- 21 Nov 2007 Discontinued - Phase-II for Acute hypoxia in France (IV)
- 08 Feb 2007 Phase-II clinical trials in the prevention of post-operative ileus resulting from hypoxia in France(IV)
- 20 Dec 2006 French Competent Authority has granted approval to initiate a phase II trial